Case Competition
Race to Vaccinate

Appearing on CNBC’s Power Lunch, core faculty member and Rutgers vice chancellor Reynold Panettieri discusses the Johnson & Johnson COVID-19 vaccine, infection rates and hospitalizations, and effective public health measures.

Rutgers professor explains consequences of coronavirus vaccine hoarding

The global health consequences and moral implications of wealthy countries hoarding vaccines could be quite serious, said institute director Richard Marlink in a story published by The Daily Targum.

When it comes to vaccine efficacy, here’s why 94% isn’t much different than 72%

In an interview about the efficacy of COVID-19 vaccines, institute director Richard Marlink responds to public opinion about the differences among vaccines that are authorized or in the pipeline for use in the United States.

The Impact of the U.S. Re-engaging with the World Health Organization

The importance of a global COVID-19 vaccination strategy and how WHO involvement benefits the U.S. overall are topics that institute director Richard Marlink discusses in this Q&A.

Getting Back to Work and School Safely During COVID-19: ITI Students Help Launch HLTH I.D

School of Communication and Information students developed an app intended to detect COVID-19. Institute director Richard Marlink was the student team’s industry mentor in the Rutgers I-Corps program.

Will you need an annual vaccination for COVID-19?

In a television interview broadcast by NJ Spotlight News, institute director Richard Marlink discusses the COVID-19 vaccine. Topics include how long immunity might last and roadblocks in rolling out a vaccination program.

Rutgers expert: We likely will need COVID-19 vaccines annually

In an interview about COVID-19 vaccines, institute director Richard Marlink discusses that people may need to get vaccinated annually as well as the importance of a global approach to controlling the pandemic.

Members of Congress face backlash as they get priority for scarce vaccine

Rutgers Global Health Institute director Richard Marlink is among the “experts, pundits, and social media users” interviewed for a national story about U.S. Congress members being among the first to receive coronavirus vaccines.